Alzheimer’s Association. 2022 Alzheimer’s disease facts and figures. Alzheimers Dement. 18, 700–789 (2022).

Hampel, H. et al. The amyloid-β pathway in Alzheimer’s disease. Mol. Psychiatry 26, 5481–5503 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hampel, H. et al. Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat. Rev. Neurol. 17, 580–589 (2021).

Article  PubMed  Google Scholar 

Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C. C. & Bu, G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat. Rev. Neurol. 15, 501–518 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Genin, E. et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol. Psychiatry 16, 903–907 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923 (1993).

Article  CAS  PubMed  Google Scholar 

Belloy, M. E. et al. APOE genotype and Alzheimer disease risk across age, sex, and population ancestry. JAMA Neurol. 80, 1284–1294 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA 278, 1349–1356 (1997).

Article  CAS  PubMed  Google Scholar 

Neu, S. C. et al. Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis. JAMA Neurol. 74, 1178–1189 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Chen, Y., Strickland, M. R., Soranno, A. & Holtzman, D. M. Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis. Neuron 109, 205–221 (2021).

Article  CAS  PubMed  Google Scholar 

Linton, M. F. et al. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88, 270–281 (1991).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahley, R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622–630 (1988).

Article  CAS  PubMed  Google Scholar 

Stuchell-Brereton, M. D. et al. Apolipoprotein E4 has extensive conformational heterogeneity in lipid-free and lipid-bound forms. Proc. Natl Acad. Sci. USA 120, e2215371120 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reiman, E. M. et al. Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat. Commun. 11, 667 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaup, A. R. et al. Cognitive resilience to apolipoprotein E ε4: contributing factors in Black and white older adults. JAMA Neurol. 72, 340–348 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Zheng, L. et al. Gender specific factors contributing to cognitive resilience in APOE ε4 positive older adults in a population-based sample. Sci. Rep. 13, 8037 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Utermann, G., Hees, M. & Steinmetz, A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 269, 604–607 (1977).

Article  CAS  PubMed  Google Scholar 

Corder, E. H. et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7, 180–184 (1994).

Article  CAS  PubMed  Google Scholar 

Naslavsky, M. S. et al. Global and local ancestry modulate APOE association with Alzheimer’s neuropathology and cognitive outcomes in an admixed sample. Mol. Psychiatry 27, 4800–4808 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, Q., Wang, T., Kang, D. & Chen, L. Protective effect of apolipoprotein E ε3 on sporadic Alzheimer’s disease in the Chinese population: a meta-analysis. Sci. Rep. 12, 13620 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nishita, Y. et al. Effects of APOEε4 genotype on age-associated change in cognitive functions among Japanese middle-aged and older adults: a 20-year follow-up study. Exp. Gerontol. 171, 112036 (2023).

Article  CAS  PubMed  Google Scholar 

Ali, M. et al. Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease. Acta Neuropathol. Commun. 11, 68 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Serrano-Pozo, A., Das, S. & Hyman, B. T. APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 20, 68–80 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cacace, R., Sleegers, K. & Van Broeckhoven, C. Molecular genetics of early-onset Alzheimer’s disease revisited. Alzheimers Dement. 12, 733–748 (2016).

Article  PubMed  Google Scholar 

van Duijn, C. M. et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer’s disease. Nat. Genet. 7, 74–78 (1994).

Article  PubMed  Google Scholar 

Polsinelli, A. J. et al. APOE ε4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD. Alzheimers Dement. 19, 2212–2217 (2023).

Article  CAS  PubMed  Google Scholar 

Polsinelli, A. J. et al. APOE ε4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer’s disease. Alzheimers Dement. 19, 1983–1993 (2023).

Bu, G. APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants. Mol. Neurodegener. 17, 51 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Arboleda-Velasquez, J. F. et al. Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report. Nat. Med. 25, 1680–1683 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sepulveda-Falla, D. et al. Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia. Acta Neuropathol. 144, 589–601 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fagan, A. M. et al. Human and murine ApoE markedly alters Aβ metabolism before and after plaque formation in a mouse model of Alzheimer’s disease. Neurobiol. Dis. 9, 305–318 (2002).

Article  CAS  PubMed  Google Scholar 

Holtzman, D. M. et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s disease. Proc. Natl Acad. Sci. USA 97, 2892–2897 (2000).